Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2080 of 6351
-
Can a diabetes drug duo protect your heart?
Disease control Recruiting nowA. Four groups of patients with type 2 diabetes mellitus with high or very high cardiovascular risk or heart failure with preserved ejection fraction (HFpEF) will be studied before and at 6 and 12 months of treatment: * 60 patients treated with a combination of GLP1 analogue and…
Sponsor: University of Athens • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Lullabies as medicine: can music ease opioid withdrawal in newborns?
Symptom relief Recruiting nowThis study examines the effects of 6 different music therapy interventions on outcomes for neonates diagnosed with Neonatal Abstinence Syndrome.
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Ear zap may calm lupus pain by taming inflammation
Symptom relief CompletedSystemic Lupus Erythematosus (SLE) is a chronic autoimmune, inflammatory disease and musculoskeletal pain is one of the most common symptoms. This study will investigate whether transcutaneous stimulation of the vagus nerve will decrease lupus musculoskeletal pain. This study wil…
Sponsor: Northwell Health • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New asthma pill shows promise in large trial
Disease control CompletedA randomized, multicenter, double-blind, placebo- controlled parallel-group study to determine the efficacy and safety of QAW039, compared with placebo, when added to standard-of-care (SoC) asthma therapy in adult and adolescent (≥ 12 years) patients with uncontrolled asthma with…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New chemo approach may cut bladder cancer return rates
Disease control CompletedA randomized controlled trial aiming to investigate neoadjuvant, short-term intensive chemoresection with Mitomycin C compared to standard treatment with TURB and adjuvant intravesical instillation therapy in patients with recurrent non-muscle invasive bladder cancer (NMIBC).
Phase 4 • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New asthma pill shows promise in large trial
Disease control CompletedA randomized, multicenter, double-blind, placebo- controlled parallel-group study to determine the efficacy and safety of QAW039, compared with placebo, when added to standard-of-care (SoC) asthma therapy in adult and adolescent (≥ 12 years) patients with uncontrolled asthma with…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could donor milk give late preterm babies a healthier start than formula?
Disease control PausedLate preterm infants, who are born at 34, 35 or 36 weeks gestation, often have difficulty feeding, establishing growth, and fighting off infection. Breastfeeding provides improved nutrition to help fight infection, in part because breast milk encourages the growth of healthy bact…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain implant that turns on only when pain strikes shows promise
Symptom relief CompletedDeep brain stimulation (DBS) holds promise as a new option for patients suffering from treatment-resistant chronic pain, but current technology is unable to reliably achieve long-term pain symptom relief. A "one-size-fits-all" approach of continuous, 24/7 brain stimulation has he…
Sponsor: Prasad Shirvalkar, MD, PhD • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
New chimney graft study aims to fix tricky aortic aneurysms without open surgery
Disease control OngoingThe purpose of the post-market study is to assess the clinical outcomes, safety, and performance of the Endurant Chimney Graft Technique (Endurant Stent Graft Systems used with a balloon-expandable covered stent graft) for treatment of juxtarenal aortic aneurysms with a short inf…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Lung cancer drug under watch: new study tracks Real-World safety
Disease control CompletedThe objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in this surveillance, and 3)factors considered to affect the safety and/or efficacy of…
Sponsor: Pfizer • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Heart valve clip shows promise for heart failure patients in Real-World study
Disease control CompletedThe COAPT Continued Access Study (CAS) is an extension of the COAPT RCT under the same IDE (G120024). COAPT CAS was a single-arm, prospective, multicenter continued access registry that enrolled heart failure patients with secondary mitral regurgitation who remained symptomatic d…
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a blood test reveal why the flu shot fails some people?
Knowledge-focused CompletedBetter understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte res…
Phase 4 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Immunotherapy combo shows promise in ovarian cancer trial
Disease control CompletedThis is a randomized, open, comparative, multi-centre study which will recruit up to 66 patients. The objective is mainly to explore the safety and feasibility in neo-adjuvant first-line ovarian cancer (including patients with primary peritoneal or fallopian tube adenocarcinoma) …
Phase 1/2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could MRI replace CT for abdominal pain in young women, cutting radiation?
Diagnosis Stopped earlyObjective : To demonstrate diagnostic performances of Magnetic Resonance Imaging (MRI) as compared to Computed Tomography (CT) as a second intention imaging modality in young women with acute non traumatic abdominopelvic pain and non contributive ultrasonography.
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy aims to tame advanced melanoma
Disease control CompletedThis is a Phase 1b, open-label study of immune checkpoints inhibitors Nivolumab+Ipilimumab administered in combination with the anti-TNF-α either Infliximab or Certolizumab, in patients with advanced melanoma.
Phase 1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo attack on liver tumors shows promise in early trial
Disease control CompletedThis research study is studying a drug in combination with radiation therapy as a possible treatment for hepatic metastases from colorectal cancer. The interventions involved in this study are: * Trifluridine (TAS-102) * Radiation Therapy
Phase 1/2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Laser or freezing: a gentler approach to prostate cancer?
Disease control By invitation onlyBackground: Prostate cancer is the most common non-skin cancer in U.S. men. Treatments for early or less aggressive disease are limited. Researchers want to test a device that destroys cancerous tissue with laser energy. They want to see if using it with ultrasound is more comfo…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Targeted drug shows promise for Hard-to-Treat lung cancer
Disease control Stopped earlyThis is a Phase 2, open-label, multi-center study to evaluate the efficacy and the safety/tolerability of poziotinib in seven participant cohorts for up to 603 previously treated and treatment-naïve NSCLC participant. Cohorts 3 and 4 were added with Amendment 1 and three addition…
Phase 2 • Sponsor: Spectrum Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Lung cancer screening sites test best ways to help smokers quit
Disease control OngoingThis study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benef…
Phase 4 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New pill could cool down menopause hot flashes
Symptom relief CompletedThe purpose of this study is to assess the efficacy and safety of MT-8554 for treatment of vasomotor symptoms (VMS) associated with menopause.
Phase 2 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC